The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

United Therapeutics Corp

Nasdaq: UTHR
Last

(U.S.) $110.19

Today's change+4.99 +4.74%
Updated May 2 4:00 PM EDT. Delayed by at least 15 minutes.
 

United Therapeutics Corp

Nasdaq: UTHR
Last

(U.S.) $110.19

Today's change+4.99 +4.74%
Updated May 2 4:00 PM EDT. Delayed by at least 15 minutes.

United Therapeutics Corp up sharply

United Therapeutics Corp closed up sharply Monday, rallying (U.S.)$4.99 or 4.74% to (U.S.)$110.19. Over the last five days, shares have lost 6.06% and are down 29.64% for the last year to date. This security has underperformed the S&P 500 by 34.26% during the last year.

Key company metrics

  • Open(U.S.) $105.49
  • Previous close(U.S.) $105.20
  • High(U.S.) $110.55
  • Low(U.S.) $104.90
  • Bid / Ask(U.S.) $109.50 / (U.S.) $115.00
  • YTD % change-29.64%
  • Volume980,712
  • Average volume (10-day)794,545
  • Average volume (1-month)880,662
  • Average volume (3-month)780,449
  • 52-week range(U.S.) $102.50 to (U.S.) $190.13
  • Beta1.58
  • Trailing P/E6.09×
  • P/E 1 year forward7.47×
  • Forward PEG4.53×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $18.10
Updated May 2 4:00 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue369405386347
Total other revenue--------
Total revenue369405386347
Gross profit368380379331
Total cost of revenue125716
Total operating expense5250-1175
Selling / general / administrative5149-17110
Research & development0761049
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income364155387172
Interest income (expense), net non-operating-1-1-1-1
Gain (loss) on sale of assets--0350--
Other--------
Income before tax364156737168
Income after tax23610546499
Income tax, total1285127269
Net income23610546499
Total adjustments to net income--------
Net income before extra. items23610546499
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items23610546499
Inc. avail. to common incl. extra. items23610546499
Diluted net income23610546499
Dilution adjustment--------
Diluted weighted average shares49505052
Diluted EPS excluding extraordinary itemsvalue per share4.842.109.241.91
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share4.842.104.851.91